The company have significantly improved the progress of a novel therapy for cardiac amyloidosis, utilizing the compound. Early trial data indicates promising outcomes for individuals suffering with the serious disease. https://attrcm103863.blogdigy.com/bridgebio-improves-attr-cm-treatment-using-the-drug-68379635